Bob Okunski
Vice President of Investor Relations
Replay available
Option Care Health, Inc. (NASDAQ: OPCH) Q2 2026 earnings conference call, held 2026-07-29. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
President and Chief Executive Officer
Executive Vice President and Chief Financial Officer
Analyst, J.P. Morgan
Analyst, Truist
Analyst, Jefferies
Analyst, Goldman Sachs
Analyst, Morgan Stanley
Analyst, Deutsche Bank
Analyst, Bank of America
Analyst, Stephens
Analyst, TD Cal
Analyst, William Blair
Good day and welcome to the Option Care Health second quarter 2026 earnings call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Mr. Bob Okunski, Vice President of Investor Relations. Please go ahead. Good morning and welcome to OptumCare Health's second quarter 2026 earnings conference call. With me today are John Rademacher, President and Chief Executive Officer, and Meenal Sethna, Executive Vice President and Chief Financial Officer. Before we begin, a reminder that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations. These forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from our expectations. We assume no obligation to update any forward-looking statements except as required by law. We will also use non-GAAP financial measures when talking about the company's performance and financial condition. For more information on the specific risks and uncertainties, as well as our non-GAAP measures, we encourage you to review the information in today's press release, which is posted on the investor relations portion of our website, as well as in our form 10-K and 10-Q filed with the SEC. Finally, for the question and answer portion of today's call, we ask that you limit questions to one question and one follow-up per...